http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2339379-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8ee484f4ba9a0406b8927b5be6c4f2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593 |
filingDate | 2007-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f99e05e74eab6792b83e8ff9939c2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0885438f767d7bd0986ab9a1384c88b |
publicationDate | 2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2339379-C1 |
titleOfInvention | Method for optimisation of thrombocyte receptivity to aggregation inducers in metabolic syndrome |
abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, particularly to haematology and endocrinology, and deals with optimisation of thrombocyte receptivity to aggregation inducers in metabolic syndrome patients. For this purpose individually selected low-calorie diet, and drugs: 10 mg amploidine every morning, duovit by 1 red tablet and 1 blue one daily, are administered. The course duration is at least 12 weeks. n EFFECT: allows normalisation of thrombocyte receptivity to aggregation inducers, resulted in significant reducing the risk of thrombosis complications in metabolic syndrome. n 2 tbl, 1 ex, 3 dwg |
priorityDate | 2007-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.